Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name

🎁 $75,000 HOLIDAY MATCH IS LIVE🎁

Make a gift during the season of giving!

EOY Giving 2025 Match Your Gift

HELP 🔓 $100,000 IN LIFESAVING SUPPORT 💙

ONE DAY ONLY: Help ZERO raise $20,000

and unlock Harrity & Harrity's $80,000 match!

H4C EOY Giving Donate Now

Targeted ‘radioligand’ improves survival in advanced prostate cancer

cells

Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy. The injected treatment combines a targeting compound with a radioactive isotope to irradiate and kill cancer cells.

Read the full article here

Share